Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TopROC: Transoral Surgery vs Radiochemotherapy for Oropharyngeal Cancer
NCT03691441Phase 4Unknown
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2018
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in oropharyngeal cancer (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Time to local or locoregional failure or death from any cause at 36 months. Status: unknown.
02
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on NCT03691441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691441.